Prabhjot S Mundi
Publication Activity (10 Years)
Years Active: 2023-2024
Publications (10 Years): 8
Publications (10 Years): 8
Publications
- Yaniv Kazansky, Helen S Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Prabhjot S Mundi, Yasumichi Kuwahara, Romel Somwar, Rui Qu, Andrea Califano, Elisa de Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
- Yaniv Kazansky, Helen S Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Prabhjot S Mundi, Yasumichi Kuwahara, Romel Somwar, Rui Qu, Andrea Califano, Elisa de Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
- Jeremy Worley, Heeju Noh, Daoqi You, Mikko M Turunen, Hongxu Ding, Evan Paull, Aaron T Griffin, Adina Grunn, Mingxuan Zhang, Kristina Guillan, Erin C Bush, Samantha J Brosius, Hanina Hibshoosh, Prabhjot S Mundi, Peter Sims, Piero Dalerba, Filemon Dela Cruz, Andrew L Kung, Andrea Califano
- Yaniv Kazansky, Helen S Mueller, Daniel Cameron, Phillip Demarest, Nadia Zaffaroni, Noemi Arrighetti, Valentina Zuco, Prabhjot S Mundi, Yasumichi Kuwahara, Romel Somwar, Rui Qu, Andrea Califano, Elisa de Stanchina, Filemon Dela Cruz, Andrew L Kung, Mrinal M Gounder, Alex Kentsis
- Jeremy Worley, Heeju Noh, Daoqi You, Mikko M Turunen, Hongxu Ding, Evan Paull, Aaron T Griffin, Adina Grunn, Mingxuan Zhang, Kristina Guillan, Erin C Bush, Samantha J Brosius, Hanina Hibshoosh, Prabhjot S Mundi, Peter Sims, Piero Dalerba, Filemon Dela Cruz, Andrew L Kung, Andrea Califano
- Jeremy Worley, Heeju Noh, Daoqi You, Mikko M Turunen, Hongxu Ding, Evan Paull, Aaron T Griffin, Adina Grunn, Mingxuan Zhang, Kristina Guillan, Erin C Bush, Samantha J Brosius, Hanina Hibshoosh, Prabhjot S Mundi, Peter Sims, Piero Dalerba, Filemon Dela Cruz, Andrew L Kung, Andrea Califano
- Prabhjot S Mundi, Filemon Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R Rainey, Kristina Guillan, Armaan Siddiquee, Daoqi You, Ronald Realubit, Charles Karan, Michael V Ortiz, Eugene F Douglass, Melissa K Accordino, Suzanne Mistretta, Frances L Brogan, Jeffrey N Bruce, Cristina I Caescu, Richard D Carvajal, Katherine D Crew, Guarionex Decastro, Mark Heaney, Brian S Henick, Dawn L Hershman, June Y Hou, Fabio M Iwamoto, Joseph G Jurcic, Ravi P Kiran, Michael D Kluger, Teri Kreisl, Nicole Lamanna, Andrew B Lassman, Emerson A Lim, Gulam A Manji, Guy M McKhann, James M McKiernan, Alfred I Neugut, Kenneth P Olive, Todd Rosenblat, Gary K Schwartz, Catherine A Shu, Michael B Sisti, Ana I Tergas, Reena M Vattakalam, Mary R Welch, Sven Wenske, Jason D Wright, Peter Canoll, Hanina Hibshoosh, Kevin M Kalinsky, Mahalaxmi Aburi, Peter A Sims, Mariano J Alvarez, Andrew L Kung, Andrea Califano
- Kevin M Kalinsky, Melissa K Accordino, Codruta Chiuzan, Prabhjot S Mundi, Elizabeth Sakach, Claire Sathe, Heejoon Ahn, Meghna S Trivedi, Yelena Novik, Amy Tiersten, George Raptis, Lea N Baer, Sun Y Oh, Amelia B Zelnak, Kari B Wisinski, Eleni Andreopoulou, William J Gradishar, Erica M Stringer-Reasor, Sonya A Reid, Anne O'Dea, Ruth M O'Regan, Katherine D Crew, Dawn L HershmanRandomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)